Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EV/Core EBITDA

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 31.0919.4831.1331.3232.67

What is the latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH ?

The latest EV/Core EBITDA ratio of MEDICAMEN BIOTECH is 31.09 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202531.09
Mar202419.48
Mar202331.13
Mar202231.32
Mar202132.67

How is EV/Core EBITDA of MEDICAMEN BIOTECH Trending?

Years EV/Core EBITDA % Change
Mar2025 31.09
59.60
Mar2024 19.48
-37.42
Mar2023 31.13
-0.61
Mar2022 31.32
-4.13
Mar2021 32.67 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EV/Core EBITDA ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹566.7 Cr 3.1% 17% -7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹425,102.0 Cr -0.7% 4.3% 0.2% Stock Analytics
DIVIS LABORATORIES ₹170,299.0 Cr -0.6% -2.6% 6.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,753.0 Cr 0.4% 4.7% 19.8% Stock Analytics
CIPLA ₹121,735.0 Cr -1.3% -4.8% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,155.0 Cr -1.1% -3.7% 2.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

3.1%

17%

-7%

SENSEX

-0.1%

0%

9%


You may also like the below Video Courses